Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1965 1
1966 4
1967 5
1968 6
1969 4
1970 5
1971 5
1972 3
1973 9
1974 11
1975 12
1976 15
1977 10
1978 13
1979 14
1980 17
1981 9
1982 12
1983 11
1984 14
1985 17
1986 12
1987 7
1988 17
1989 12
1990 12
1991 14
1992 6
1993 12
1994 13
1995 15
1996 18
1997 12
1998 12
1999 8
2000 15
2001 14
2002 11
2003 13
2004 13
2005 12
2006 9
2007 6
2008 10
2009 13
2010 11
2011 12
2012 19
2013 24
2014 28
2015 32
2016 35
2017 27
2018 29
2019 24
2020 32
2021 27
2022 29
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

762 results

Results by year

Filters applied: . Clear all
Page 1
SGLT2-inhibitors; more than just glycosuria and diuresis.
Fathi A, Vickneson K, Singh JS. Fathi A, et al. Heart Fail Rev. 2021 May;26(3):623-642. doi: 10.1007/s10741-020-10038-w. Epub 2020 Dec 4. Heart Fail Rev. 2021. PMID: 33274396 Free PMC article. Review.
The sodium-glucose linked cotransporter subtype 2 (SGLT2)-inhibitor class, which was initially developed as a treatment for T2DM, has shown great promise in reducing cardiovascular risk, particularly around HF outcomes - regardless of diabetes status.There are ongoing efforts to …
The sodium-glucose linked cotransporter subtype 2 (SGLT2)-inhibitor class, which was initially developed as a treatment for T2DM, has shown …
Drug-induced renal Fanconi syndrome.
Hall AM, Bass P, Unwin RJ. Hall AM, et al. QJM. 2014 Apr;107(4):261-9. doi: 10.1093/qjmed/hct258. Epub 2013 Dec 24. QJM. 2014. PMID: 24368854 Review.
The clinical features of FS are amino aciduria, low molecular weight proteinuria, hypophosphataemia, metabolic acidosis and glycosuria. The most serious complications are bone demineralization from urinary phosphate wasting and progressive decline in kidney function. ...
The clinical features of FS are amino aciduria, low molecular weight proteinuria, hypophosphataemia, metabolic acidosis and glycosuria …
SGLT-2 inhibitors: Their pleiotropic properties.
Vallianou NG, Geladari E, Kazazis CE. Vallianou NG, et al. Diabetes Metab Syndr. 2017 Oct-Dec;11(4):311-315. doi: 10.1016/j.dsx.2016.12.003. Epub 2016 Dec 9. Diabetes Metab Syndr. 2017. PMID: 28011230 Review.
The sodium glucose co-transporters 2 inhibitors are a new class of glucose-lowering agents, which act through a novel mechanism by producing a decline in glucose re-absorption in the kidney, thereby increasing glycosuria and decreasing serum glucose levels. Data suggest th …
The sodium glucose co-transporters 2 inhibitors are a new class of glucose-lowering agents, which act through a novel mechanism by producing …
Diabetes in pregnancy.
Bassaw B, Ataullah I, Roopnarinesingh S, Sirjusingh A. Bassaw B, et al. Int J Gynaecol Obstet. 1995 Jul;50(1):5-9. doi: 10.1016/0020-7292(95)02390-x. Int J Gynaecol Obstet. 1995. PMID: 7556860
RESULTS: Risk factors for the development of diabetes included age ( > 25 years), East Indian ethnic origin, glycosuria, and a history of diabetes in a first-degree relative. Treatment consisted of diet alone or in combination with soluble insulin. ...
RESULTS: Risk factors for the development of diabetes included age ( > 25 years), East Indian ethnic origin, glycosuria, and a his …
Cadmium nephropathy.
Kazantzis G. Kazantzis G. Contrib Nephrol. 1979;16:161-6. doi: 10.1159/000402891. Contrib Nephrol. 1979. PMID: 223811
In a group of 12 cadmium workers some of whom were followed for up to 16 years, tubular proteinuria, renal glycosuria, aminoaciduria, hypercalciuria and defects of concentration and acidification have been observed. ...
In a group of 12 cadmium workers some of whom were followed for up to 16 years, tubular proteinuria, renal glycosuria, aminoaciduria, …
Glycosuria in primary glomerulopathies: prevalence and prognostic significance.
Ormonde C, Laranjinha I, Gil C, Gonçalves M, A Gaspar A. Ormonde C, et al. J Bras Nefrol. 2022 Jan-Mar;44(1):26-31. doi: 10.1590/2175-8239-JBN-2021-0115. J Bras Nefrol. 2022. PMID: 34424258 Free PMC article.
The aim of this study was to evaluate the prevalence and prognostic value of glycosuria at the time of diagnosis in primary glomerulopathies (PG). ...CONCLUSION: Ten percent of our patients with PG have glycosuria. Glycosuria at the time of diagnosis was asso …
The aim of this study was to evaluate the prevalence and prognostic value of glycosuria at the time of diagnosis in primary glomerulo …
SGLT2 Inhibition in the Diabetic Kidney-From Mechanisms to Clinical Outcome.
van Bommel EJM, Muskiet MHA, Tonneijck L, Kramer MHH, Nieuwdorp M, van Raalte DH. van Bommel EJM, et al. Clin J Am Soc Nephrol. 2017 Apr 3;12(4):700-710. doi: 10.2215/CJN.06080616. Epub 2017 Mar 2. Clin J Am Soc Nephrol. 2017. PMID: 28254770 Free PMC article. Review.
Inhibiting these transporters has been shown to effectively improve glycemic control through inducing glycosuria and is generally well tolerated, although patients experience more genital infections. ...
Inhibiting these transporters has been shown to effectively improve glycemic control through inducing glycosuria and is generally wel …
The role of sodium glucose co-transporter inhibitors in heart failure prevention.
Garla V, Subauste A, Butler J, Lien LF. Garla V, et al. J Diabetes Complications. 2021 Mar;35(3):107811. doi: 10.1016/j.jdiacomp.2020.107811. Epub 2020 Nov 26. J Diabetes Complications. 2021. PMID: 33280983 Review.
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are agents approved for the treatment of DM; they exert their anti-hyperglycemic effects by blocking renal reabsorption of glucose and inducing glycosuria. SGLT-2 inhibitors have consistently decreased the hospitalization …
Sodium-glucose co-transporter-2 (SGLT-2) inhibitors are agents approved for the treatment of DM; they exert their anti-hyperglycemic effects …
DRUG-RELATED URINARY TRACT INFECTIONS.
Dobrek Ł. Dobrek Ł. Wiad Lek. 2021;74(7):1728-1736. Wiad Lek. 2021. PMID: 34459779 Free article.
Among drugs associated with an increased risk of UTI development one should mention immunosuppressants, agents affecting normal voiding processes and increasing the intravesical volume of residual urine, drugs promoting lithogenesis in the urinary tract with the subsequent favour …
Among drugs associated with an increased risk of UTI development one should mention immunosuppressants, agents affecting normal voiding proc …
Phenotype standardization for drug-induced kidney disease.
Mehta RL, Awdishu L, Davenport A, Murray PT, Macedo E, Cerda J, Chakaravarthi R, Holden AL, Goldstein SL. Mehta RL, et al. Kidney Int. 2015 Aug;88(2):226-34. doi: 10.1038/ki.2015.115. Epub 2015 Apr 8. Kidney Int. 2015. PMID: 25853333 Free PMC article.
762 results